<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910703-0128</DOCNO><DOCID>910703-0128.</DOCID><HL>   Technology:   Somatogen Receives a Patent</HL><DATE>07/03/91</DATE><SO>WALL STREET JOURNAL (J), PAGE B2</SO><GV>COMMERCE DEPARTMENT (COM)</GV><RE>COLORADO (CO)NORTH AMERICA (NME)UNITED STATES (US)</RE><LP>   BOULDER, Colo. -- Somatogen said it received a patent forblood-substitute products based on hemoglobin, which has beengenetically engineered to improve how it delivers oxygen totissues.   The company, which is trying to develop a bloodsubstitute, said its patent includes claims for hemoglobinvariants and how they are used as a blood substitute. Thecompany said the technology was jointly developed bySomatogen and the Medical Research Council in Europe.</LP><TEXT/></DOC>